首页 > 最新文献

Revista clinica espanola最新文献

英文 中文
Presente y futuro de los médicos internistas en la sanidad pública española 西班牙公共卫生中内科医生的现状和未来
IF 2.3 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-04-01 DOI: 10.1016/j.rce.2025.01.002
N. Ramírez-Perea , D. Orozco-Beltrán
{"title":"Presente y futuro de los médicos internistas en la sanidad pública española","authors":"N. Ramírez-Perea , D. Orozco-Beltrán","doi":"10.1016/j.rce.2025.01.002","DOIUrl":"10.1016/j.rce.2025.01.002","url":null,"abstract":"","PeriodicalId":21223,"journal":{"name":"Revista clinica espanola","volume":"225 4","pages":"Pages 250-251"},"PeriodicalIF":2.3,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143738416","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
RECALMIN V. Evolución de la actividad de las unidades de medicina interna del Sistema Nacional de Salud (2007-2022) RECALMIN V.国家卫生系统内科单位活动的演变(2007-2022年)
IF 2.3 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-04-01 DOI: 10.1016/j.rce.2024.10.011
J. Carretero Gómez , M.M. Chimeno Viñas , J.M. Porcel Pérez , M. Méndez Bailón , P. Pérez Martínez , M.T. Herranz Marín , N. del Prado , F.J. Elola Somoza

Objectives

To analyse the structure, activity and results of the internal medicine units (IMUs) of the Spanish National Health System (SNHS). To compare the results of the RECALMIN 2023 survey with previous waves of surveys of the UMIs (2008, 2015, 2017, 2019, 2021) and to analyse trends in the structure, activity and results of the UMIs.

Material and methods

There were 2 data sources: 1) survey on UMI structure and activity, and 2) hospital discharges of UMIs from the Minimum and Basic Data Set (CMBD) of the SNHS. Cross-sectional descriptive study of the UMIs in acute hospitals of the SNHS with data referring to 2022, comparing them with previous studies.

Results

Over the period 2007-2022, the rate of internists per 100,000 inhabitants increased (incidence rate ratio [IRR]: 4.5%; p < 0.001). Inpatient discharges per population and the number of discharges by UMI (IRR: 2.6%, p = 0.005; IRR: 3.5%, p < 0.001, respectively) also increased. The UMIs account for 20% of discharges from general hospitals in the NHS. The Internal Medicine Spanish Society has a database of the CMBD_MIN 2007-2022 with 9,931,401 discharges given by the UMI. The crude in-hospital hospital mortality rate increased in the period 2007-2022 (p < 0.001). From 2020 onwards (SARS-CoV-2 pandemic) overall risk-adjusted and process-adjusted mortality increased (p < 0.001).

Conclusions

UMIs have a central position in SNHS hospital care. The activity of the UMI has grown significantly in the period analysed. The RECALMIN project identifies strengths and opportunities to be strategically addressed by Internal Medicine Spanish Society.
目的分析西班牙国家卫生系统(SNHS)内科单元(imu)的结构、活动和结果。将RECALMIN 2023调查结果与之前的UMIs调查(2008年、2015年、2017年、2019年、2021年)进行比较,并分析UMIs的结构、活动和结果的趋势。材料与方法数据来源:1)全国统一医院结构与活动调查;2)全国统一医院最小基本数据集(CMBD)统一医院出院情况。以2022年为数据对SNHS急症医院的UMIs进行横断面描述性研究,并与以往研究进行比较。结果2007-2022年,每10万居民内科医生的发病率(发病率比[IRR]: 4.5%;p & lt;0.001)。人均住院出院人数和UMI出院人数(IRR: 2.6%, p = 0.005;内部收益率:3.5%,p <;0.001)也增加了。综合医院占国民保健制度综合医院出院人数的20%。西班牙内科学会拥有2007-2022年CMBD_MIN数据库,其中有9,931,401例出院病例。2007-2022年期间,医院内粗死亡率上升(p <;0.001)。从2020年起(SARS-CoV-2大流行),总体风险调整和过程调整死亡率增加(p <;0.001)。结论护士在SNHS医院护理中处于中心地位。在所分析的期间内,统检组的活动显著增加。RECALMIN项目确定了西班牙内科学会战略性地解决的优势和机会。
{"title":"RECALMIN V. Evolución de la actividad de las unidades de medicina interna del Sistema Nacional de Salud (2007-2022)","authors":"J. Carretero Gómez ,&nbsp;M.M. Chimeno Viñas ,&nbsp;J.M. Porcel Pérez ,&nbsp;M. Méndez Bailón ,&nbsp;P. Pérez Martínez ,&nbsp;M.T. Herranz Marín ,&nbsp;N. del Prado ,&nbsp;F.J. Elola Somoza","doi":"10.1016/j.rce.2024.10.011","DOIUrl":"10.1016/j.rce.2024.10.011","url":null,"abstract":"<div><h3>Objectives</h3><div>To analyse the structure, activity and results of the internal medicine units (IMUs) of the Spanish National Health System (SNHS). To compare the results of the RECALMIN 2023 survey with previous waves of surveys of the UMIs (2008, 2015, 2017, 2019, 2021) and to analyse trends in the structure, activity and results of the UMIs.</div></div><div><h3>Material and methods</h3><div>There were 2 data sources: 1) survey on UMI structure and activity, and 2) hospital discharges of UMIs from the Minimum and Basic Data Set (CMBD) of the SNHS. Cross-sectional descriptive study of the UMIs in acute hospitals of the SNHS with data referring to 2022, comparing them with previous studies.</div></div><div><h3>Results</h3><div>Over the period 2007-2022, the rate of internists per 100,000 inhabitants increased (incidence rate ratio [IRR]: 4.5%; p<!--> <!-->&lt;<!--> <!-->0.001). Inpatient discharges per population and the number of discharges by UMI (IRR: 2.6%, p<!--> <!-->=<!--> <!-->0.005; IRR: 3.5%, p<!--> <!-->&lt;<!--> <!-->0.001, respectively) also increased. The UMIs account for 20% of discharges from general hospitals in the NHS. The Internal Medicine Spanish Society has a database of the CMBD_MIN 2007-2022 with 9,931,401 discharges given by the UMI. The crude in-hospital hospital mortality rate increased in the period 2007-2022 (p &lt; 0.001). From 2020 onwards (SARS-CoV-2 pandemic) overall risk-adjusted and process-adjusted mortality increased (p &lt; 0.001).</div></div><div><h3>Conclusions</h3><div>UMIs have a central position in SNHS hospital care. The activity of the UMI has grown significantly in the period analysed. The RECALMIN project identifies strengths and opportunities to be strategically addressed by Internal Medicine Spanish Society.</div></div>","PeriodicalId":21223,"journal":{"name":"Revista clinica espanola","volume":"225 4","pages":"Pages 211-222"},"PeriodicalIF":2.3,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143738219","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Utilidad de la ecografía a pie de cama (POCUS) en el paciente hospitalizado con síndrome confusional agudo de etiología no aclarada 床下超声(POCUS)对病因不明的急性混淆综合征住院患者的效用
IF 2.3 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-04-01 DOI: 10.1016/j.rce.2024.11.002
S. Carrasco-Molina , Á. Robles-Marhuenda , J.J. Ríos-Blanco , Y. Tung-Chen
Acute confusional syndrome (ACS) is a disruption of cognitive function and attention that affects up to 42% of hospitalized patients, most commonly in those over the age of 65. It is typically triggered by one or more precipitating factors in predisposed patients. Point-of-care ultrasound (POCUS) emerges as a tool that could be used to provide quick and accurate information in the diagnosis of patients with ACS, potentially reducing the waiting time for critical interventions, decreasing the need for invasive procedures, and possibly improving clinical outcomes. To date, no articles have been published describing the utility of POCUS in patients with ACS.
Therefore, this work presents a review of the utility of POCUS in various pathologies that may be related to the development of ACS. Additionally, we propose an action algorithm that integrates clinical evaluation with bedside ultrasound, which could be useful for allowing quick and accurate identification of the underlying causes of ACS and the guidance of appropriate treatment, although prospective studies are needed to confirm this utility.
急性精神错乱综合征(ACS)是一种认知功能和注意力的紊乱,影响多达42%的住院患者,最常见于65岁以上的患者。在易感患者中,它通常由一个或多个诱发因素引发。即时超声(POCUS)作为一种工具出现,可以为ACS患者的诊断提供快速准确的信息,有可能减少关键干预的等待时间,减少对侵入性手术的需求,并可能改善临床结果。到目前为止,还没有发表文章描述POCUS在ACS患者中的应用。因此,本研究综述了POCUS在可能与ACS发展相关的各种病理中的应用。此外,我们提出了一种将临床评估与床边超声相结合的行动算法,这可能有助于快速准确地识别ACS的潜在原因并指导适当的治疗,尽管需要前瞻性研究来证实这一效用。
{"title":"Utilidad de la ecografía a pie de cama (POCUS) en el paciente hospitalizado con síndrome confusional agudo de etiología no aclarada","authors":"S. Carrasco-Molina ,&nbsp;Á. Robles-Marhuenda ,&nbsp;J.J. Ríos-Blanco ,&nbsp;Y. Tung-Chen","doi":"10.1016/j.rce.2024.11.002","DOIUrl":"10.1016/j.rce.2024.11.002","url":null,"abstract":"<div><div>Acute confusional syndrome (ACS) is a disruption of cognitive function and attention that affects up to 42% of hospitalized patients, most commonly in those over the age of 65. It is typically triggered by one or more precipitating factors in predisposed patients. Point-of-care ultrasound (POCUS) emerges as a tool that could be used to provide quick and accurate information in the diagnosis of patients with ACS, potentially reducing the waiting time for critical interventions, decreasing the need for invasive procedures, and possibly improving clinical outcomes. To date, no articles have been published describing the utility of POCUS in patients with ACS.</div><div>Therefore, this work presents a review of the utility of POCUS in various pathologies that may be related to the development of ACS. Additionally, we propose an action algorithm that integrates clinical evaluation with bedside ultrasound, which could be useful for allowing quick and accurate identification of the underlying causes of ACS and the guidance of appropriate treatment, although prospective studies are needed to confirm this utility.</div></div>","PeriodicalId":21223,"journal":{"name":"Revista clinica espanola","volume":"225 4","pages":"Pages 231-239"},"PeriodicalIF":2.3,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143738221","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
La formación en ética clínica, una herramienta necesaria para la excelencia profesional del internista 临床伦理学培训——提高内科医生专业水平的必要工具
IF 2.3 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-04-01 DOI: 10.1016/j.rce.2024.11.004
C. Font , P. Martínez de la Cruz , B. Herreros
Internists must respond to increasingly complex clinical scenarios in a context of progressively increasing life expectancy, techno-scientific development and accelerated demographic and sociocultural changes. Ethical reflection is a useful tool to resolve and prevent value conflicts, which are frequent in clinical practice. The ethical training of internists contributes to professional excellence and can be oriented at two complementary levels: 1) development of skills in all internists for the management of «clinical microethics», which allow the integration of the techno-scientific aspects of medicine in a satisfactory clinical relationship at a human level, and 2) specialization for internists who are experts in bioethics, to lead ethics committees (and other consulting models) in a more local setting and participate in bioethical debates and the development of normative ethics in a more general setting.
内科医生必须在预期寿命逐渐延长、科技发展以及人口和社会文化加速变化的背景下应对日益复杂的临床情况。伦理反思是解决和预防临床实践中常见的价值冲突的有效工具。内科医生的道德培训有助于提高专业水平,可以在两个互补的层面上进行:1)发展所有内科医生管理“临床微观伦理学”的技能,使医学的技术和科学方面能够在人类水平上与令人满意的临床关系相结合;2)生物伦理学专家的内科医生专业化,在更当地的环境中领导伦理委员会(和其他咨询模式),并参与生物伦理学的辩论和在更普遍的环境中发展规范伦理学。
{"title":"La formación en ética clínica, una herramienta necesaria para la excelencia profesional del internista","authors":"C. Font ,&nbsp;P. Martínez de la Cruz ,&nbsp;B. Herreros","doi":"10.1016/j.rce.2024.11.004","DOIUrl":"10.1016/j.rce.2024.11.004","url":null,"abstract":"<div><div>Internists must respond to increasingly complex clinical scenarios in a context of progressively increasing life expectancy, techno-scientific development and accelerated demographic and sociocultural changes. Ethical reflection is a useful tool to resolve and prevent value conflicts, which are frequent in clinical practice. The ethical training of internists contributes to professional excellence and can be oriented at two complementary levels: 1)<!--> <!-->development of skills in all internists for the management of «clinical microethics», which allow the integration of the techno-scientific aspects of medicine in a satisfactory clinical relationship at a human level, and 2)<!--> <!-->specialization for internists who are experts in bioethics, to lead ethics committees (and other consulting models) in a more local setting and participate in bioethical debates and the development of normative ethics in a more general setting.</div></div>","PeriodicalId":21223,"journal":{"name":"Revista clinica espanola","volume":"225 4","pages":"Pages 244-249"},"PeriodicalIF":2.3,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143738223","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Posicionamiento para el uso de la ecografía clínica multivaso en la evaluación del riesgo vascular: protocolo VASUS+. Recomendaciones 2024 del grupo de riesgo vascular, ecografía clínica de la Sociedad Española de Medicina Interna y Sociedad Española de Hipertensión y Riesgo Vascular 多酶临床超声在血管风险评估中的应用定位:VASUS+方案。西班牙内科学会和西班牙高血压和血管风险学会关于血管危险组、临床超声的2024年建议
IF 2.3 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-04-01 DOI: 10.1016/j.rce.2024.07.011
E. Moya Mateo , R. García Alonso , C. Sánchez Sánchez , Y. Tung-Chen , E. Rodilla , L. Beltrán Romero , J.A. García-Donaire , M.V. Bonilla-Hernández , N. Muñoz-Rivas , L. Castilla-Guerra
Atherosclerosis is the disease which underlies the entire spectrum of atherosclerotic vascular disease. Point-of-care clinical ultrasound is a useful tool for its detection. Current guidelines recommend the use of scales such as SCORE2 (Systematic Coronary Risk Evaluation 2) and SCORE2-OP (Systematic Coronary risk Evaluation 2 Older Persons) for apparently healthy individuals and those at low-intermediate risk. The guidelines recognize the role of assessing the presence of plaques via ultrasound to refine risk stratification and optimize prevention strategies. However, the method of assessing the vascular territories where plaque is present and the amount or load of plaque is not homogeneous or well protocolized. In this document, two protocols are proposed for the evaluation of vascular risk: VASUS and VASUS+, which includes the presence of ventricular hypertrophy, with the aim of standardizing clinical ultrasound in the assessment of vascular risk in clinical practice.
动脉粥样硬化是整个动脉粥样硬化性血管疾病的基础。点护理临床超声是一个有用的工具,为其检测。目前的指南建议对表面健康的个体和中低风险人群使用SCORE2(系统性冠状动脉风险评估2)和SCORE2- op(系统性冠状动脉风险评估2老年人)等量表。该指南认识到通过超声评估斑块存在的作用,以完善风险分层和优化预防策略。然而,评估斑块存在的血管区域以及斑块的数量或负荷的方法并不均匀,也没有得到很好的规范。本文提出血管风险评估的两种方案:VASUS和VASUS+,其中包括是否存在心室肥厚,旨在规范临床超声在临床实践中对血管风险的评估。
{"title":"Posicionamiento para el uso de la ecografía clínica multivaso en la evaluación del riesgo vascular: protocolo VASUS+. Recomendaciones 2024 del grupo de riesgo vascular, ecografía clínica de la Sociedad Española de Medicina Interna y Sociedad Española de Hipertensión y Riesgo Vascular","authors":"E. Moya Mateo ,&nbsp;R. García Alonso ,&nbsp;C. Sánchez Sánchez ,&nbsp;Y. Tung-Chen ,&nbsp;E. Rodilla ,&nbsp;L. Beltrán Romero ,&nbsp;J.A. García-Donaire ,&nbsp;M.V. Bonilla-Hernández ,&nbsp;N. Muñoz-Rivas ,&nbsp;L. Castilla-Guerra","doi":"10.1016/j.rce.2024.07.011","DOIUrl":"10.1016/j.rce.2024.07.011","url":null,"abstract":"<div><div>Atherosclerosis is the disease which underlies the entire spectrum of atherosclerotic vascular disease. Point-of-care clinical ultrasound is a useful tool for its detection. Current guidelines recommend the use of scales such as SCORE2 (Systematic Coronary Risk Evaluation 2) and SCORE2-OP (Systematic Coronary risk Evaluation 2 Older Persons) for apparently healthy individuals and those at low-intermediate risk. The guidelines recognize the role of assessing the presence of plaques via ultrasound to refine risk stratification and optimize prevention strategies. However, the method of assessing the vascular territories where plaque is present and the amount or load of plaque is not homogeneous or well protocolized. In this document, two protocols are proposed for the evaluation of vascular risk: VASUS and VASUS+, which includes the presence of ventricular hypertrophy, with the aim of standardizing clinical ultrasound in the assessment of vascular risk in clinical practice.</div></div>","PeriodicalId":21223,"journal":{"name":"Revista clinica espanola","volume":"225 4","pages":"Pages 223-230"},"PeriodicalIF":2.3,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143738220","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Análisis de las características clínicas y pronóstico de los pacientes con amiloidosis cardiaca ingresados en los hospitales españoles (2016-2021) 西班牙医院收治的心脏淀粉样变性患者的临床特征和预后分析(2016-2021 年)。
IF 2.3 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-02-19 DOI: 10.1016/j.rce.2024.10.007
A. Esteban-Fernández , M. Anguita-Sánchez , N. Rosillo , J.L. Bonilla-Palomas , J.L. Bernal Sobrino , N. del Prado , C. Fernández Pérez , L. Rodríguez Padial , F.J. Elola Somoza

Introduction and objectives

Cardiac amyloidosis (CA) is a prevalent yet underdiagnosed heart condition characterized by the abnormal accumulation of amyloid fibres, frequently resulting in heart failure (HF), particularly in older people. Despite advancements in non-invasive diagnostic techniques and treatments, the epidemiology of CA patients remains inadequately understood. This nationwide retrospective observational study sought to comprehensively investigate CA patients’ characteristics, mortality, and readmission patterns.

Methods

A retrospective observational study encompassed all patients hospitalized with CA between 2016 and 2021 across Spanish hospitals. Standardized incidence rates were calculated using age and sex-adjusted methods, utilizing the Spanish population as the reference. The investigation delved into demographic variables, comorbidities, mortality during the index episode, and 30 and 365-day readmissions for circulatory system diseases. Predictors of readmission were also examined.

Results

A total of 5,739 index episodes were identified, with CA being the primary cause of admission in 14.1% of cases. The mean age was 81.4 ± 9.9 years, predominantly males (70.3%). The age and sex-standardized hospital attendance rate was 3.90 admissions per 100,000 population (95% CI: 3.82-3.98), higher in males. Common comorbidities included HF (96.4%), atrial fibrillation (46.3%), and renal failure (44.4%). The mortality rate during the index episode was 11.7%, with cardiogenic shock (OR: 9.03; 95% CI: 4.22-19.32) and major psychiatric disorders (OR: 3.36; 95% CI: 1.42-7.94) identified as predictors.
Over the follow-up period, 13.1% were readmitted at 30 days and 36.6% at 365. Nephritis (IRR: 2.05; 95% CI: 1.42-2.96) and asthma (IRR: 1.52; 95% CI 1.11-2.07) were associated with increased 30-day readmissions, while renal failure (IRR: 1.43; 95% CI: 1.28-1.59) and chronic pulmonary disease (IRR: 1.40; 95% CI: 1.18-1.67) were linked to higher 365-day readmissions. Predictors of mortality risk in 365-day readmissions included advanced cancer (HR: 1.31; 95% CI: 1.00-1.71), cardiogenic shock in the index episode (HR: 2.72; 95% CI: 1.33-5.57), and a higher number of readmissions during that period (HR: 1.64; 95% CI: 1.56-1.73).

Conclusions

This study contributes valuable insights into the significant prevalence of CA, which is often overlooked and underestimated. Afflicting predominantly elderly males with concomitant HF and multiple comorbidities, CA poses a significant clinical challenge. The findings underscore the need for enhanced awareness, early detection, and a multidisciplinary approach to manage this complex cardiac condition.
简介和目的心脏淀粉样变性(CA)是一种普遍但未被诊断的心脏疾病,其特征是淀粉样纤维的异常积累,经常导致心力衰竭(HF),特别是在老年人中。尽管非侵入性诊断技术和治疗取得了进步,但CA患者的流行病学仍未得到充分了解。这项全国性的回顾性观察性研究旨在全面调查CA患者的特征、死亡率和再入院模式。方法一项回顾性观察性研究纳入了西班牙各医院2016年至2021年间所有CA住院患者。以西班牙人口为参照,采用年龄和性别调整方法计算标准化发病率。该调查深入研究了人口统计学变量、合并症、指数发作期间的死亡率,以及循环系统疾病30天和365天的再入院率。再次入院的预测因素也被检查。结果共发现5739例指标发作,14.1%的病例以CA为主要入院原因。平均年龄81.4±9.9岁,男性居多(70.3%)。年龄和性别标准化的医院出勤率为每10万人3.90人次(95% CI: 3.82-3.98),男性更高。常见的合并症包括HF(96.4%)、心房颤动(46.3%)和肾衰竭(44.4%)。指标发作期间死亡率为11.7%,其中心源性休克(OR: 9.03;95% CI: 4.22-19.32)和严重精神障碍(OR: 3.36;95% CI: 1.42-7.94)被确定为预测因子。在随访期间,13.1%的患者在30天内再次入院,36.6%的患者在365天内再次入院。肾炎(IRR: 2.05;95% CI: 1.42-2.96)和哮喘(IRR: 1.52;95% CI 1.11-2.07)与30天再入院增加相关,而肾功能衰竭(IRR: 1.43;95% CI: 1.28-1.59)和慢性肺部疾病(IRR: 1.40;95% CI: 1.18-1.67)与较高的365天再入院率有关。365天再入院的死亡风险预测因子包括晚期癌症(HR: 1.31;95% CI: 1.00-1.71),心源性休克在指数发作(HR: 2.72;95% CI: 1.33-5.57),在此期间再入院人数较高(HR: 1.64;95% ci: 1.56-1.73)。结论:本研究对经常被忽视和低估的CA的显著患病率提供了有价值的见解。主要折磨老年男性伴有心衰和多种合并症,CA提出了重大的临床挑战。研究结果强调需要提高认识,早期发现和多学科方法来管理这种复杂的心脏疾病。
{"title":"Análisis de las características clínicas y pronóstico de los pacientes con amiloidosis cardiaca ingresados en los hospitales españoles (2016-2021)","authors":"A. Esteban-Fernández ,&nbsp;M. Anguita-Sánchez ,&nbsp;N. Rosillo ,&nbsp;J.L. Bonilla-Palomas ,&nbsp;J.L. Bernal Sobrino ,&nbsp;N. del Prado ,&nbsp;C. Fernández Pérez ,&nbsp;L. Rodríguez Padial ,&nbsp;F.J. Elola Somoza","doi":"10.1016/j.rce.2024.10.007","DOIUrl":"10.1016/j.rce.2024.10.007","url":null,"abstract":"<div><h3>Introduction and objectives</h3><div>Cardiac amyloidosis (CA) is a prevalent yet underdiagnosed heart condition characterized by the abnormal accumulation of amyloid fibres, frequently resulting in heart failure (HF), particularly in older people. Despite advancements in non-invasive diagnostic techniques and treatments, the epidemiology of CA patients remains inadequately understood. This nationwide retrospective observational study sought to comprehensively investigate CA patients’ characteristics, mortality, and readmission patterns.</div></div><div><h3>Methods</h3><div>A retrospective observational study encompassed all patients hospitalized with CA between 2016 and 2021 across Spanish hospitals. Standardized incidence rates were calculated using age and sex-adjusted methods, utilizing the Spanish population as the reference. The investigation delved into demographic variables, comorbidities, mortality during the index episode, and 30 and 365-day readmissions for circulatory system diseases. Predictors of readmission were also examined.</div></div><div><h3>Results</h3><div>A total of 5,739 index episodes were identified, with CA being the primary cause of admission in 14.1% of cases. The mean age was 81.4<!--> <!-->±<!--> <!-->9.9<!--> <!-->years, predominantly males (70.3%). The age and sex-standardized hospital attendance rate was 3.90 admissions per 100,000 population (95%<!--> <!-->CI: 3.82-3.98), higher in males. Common comorbidities included HF (96.4%), atrial fibrillation (46.3%), and renal failure (44.4%). The mortality rate during the index episode was 11.7%, with cardiogenic shock (OR: 9.03; 95%<!--> <!-->CI: 4.22-19.32) and major psychiatric disorders (OR: 3.36; 95%<!--> <!-->CI: 1.42-7.94) identified as predictors.</div><div>Over the follow-up period, 13.1% were readmitted at 30<!--> <!-->days and 36.6% at 365. Nephritis (IRR: 2.05; 95%<!--> <!-->CI: 1.42-2.96) and asthma (IRR: 1.52; 95%<!--> <!-->CI 1.11-2.07) were associated with increased 30-day readmissions, while renal failure (IRR: 1.43; 95%<!--> <!-->CI: 1.28-1.59) and chronic pulmonary disease (IRR: 1.40; 95%<!--> <!-->CI: 1.18-1.67) were linked to higher 365-day readmissions. Predictors of mortality risk in 365-day readmissions included advanced cancer (HR: 1.31; 95%<!--> <!-->CI: 1.00-1.71), cardiogenic shock in the index episode (HR: 2.72; 95%<!--> <!-->CI: 1.33-5.57), and a higher number of readmissions during that period (HR: 1.64; 95%<!--> <!-->CI: 1.56-1.73).</div></div><div><h3>Conclusions</h3><div>This study contributes valuable insights into the significant prevalence of CA, which is often overlooked and underestimated. Afflicting predominantly elderly males with concomitant HF and multiple comorbidities, CA poses a significant clinical challenge. The findings underscore the need for enhanced awareness, early detection, and a multidisciplinary approach to manage this complex cardiac condition.</div></div>","PeriodicalId":21223,"journal":{"name":"Revista clinica espanola","volume":"225 3","pages":"Pages 131-139"},"PeriodicalIF":2.3,"publicationDate":"2025-02-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143479089","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hospitalizaciones por el síndrome de Takotsubo en España. Datos del CMBD por comunidades autónomas (años 2008-2021) 西班牙塔克氏综合征住院病例。按自治区分列的 CMBD 数据(2008-2021 年)
IF 2.3 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-02-07 DOI: 10.1016/j.rce.2024.10.009
N. Rosillo , N. del Prado , P. Pérez , J.L. Bernal , I. Núñez-Gil , Á. Gamarra , L. Vilches , J. Salamanca , J. Elola , F. Alfonso

Background and objectives

Takotsubo syndrome (TTS) is an infrequent cause of acute coronary syndrome much better diagnosed in recent years. This study sought to assess the clinical profile of patients admitted with TTS in Spain and to elucidate potential regional differences in admissions and in-hospital mortality between the years 2008 and 2021.

Methods

Retrospective observational study of patients admitted to acute general hospitals of the Spanish National Health System with a main or secondary diagnosis of STT, using the minimum basic data set.

Results

A total of 12.952 hospitalization for TTS were identified. The number of hospital admissions increased exponentially from 210 in the year 2008 to 1,918 in 2021. Most patients (79.1%) were women and mean age was 72.0 ± 12,5 years (72.5 ± 12,2 in female; 69.9 ± 13,4 in men; P<.001). Associated comorbidities were frequent (44.9% arterial hypertension, 31.2% heart failure) and differed in men and women. Overall, crude in-hospital mortality was 7%. Notably, admission and in-hospital mortality rates, adjusted by age and gender, were different among the different autonomous communities.

Conclusions

TTS usually presents in elderly women with associated comorbidities and has a significant in-hospital mortality. Age and comorbidities differ between men and women. Relevant regional differences exist regarding admission and in-hospital mortality rates.
背景与目的akotsubo综合征(TTS)是近年来诊断较好的一种罕见的急性冠脉综合征病因。本研究旨在评估西班牙TTS患者的临床概况,并阐明2008年至2021年间入院率和住院死亡率的潜在区域差异。方法采用最小基本数据集,对西班牙国家卫生系统急性综合医院主要或次要诊断为STT的患者进行回顾性观察研究。结果共鉴定出12.952例TTS住院病例。入院人数呈指数增长,从2008年的210人增加到2021年的1918人。患者以女性为主(79.1%),平均年龄72.0±12.5岁(女性72.5±12.2岁);男性69.9±13.4;术;措施)。相关合并症很常见(44.9%为动脉高血压,31.2%为心力衰竭),且在男性和女性中存在差异。总体而言,院内粗死亡率为7%。值得注意的是,按年龄和性别调整的住院率和住院死亡率在不同的自治区之间有所不同。结论stts常见于老年妇女,并伴有相关合并症,住院死亡率高。男性和女性的年龄和合并症不同。住院率和住院死亡率方面存在着相关的区域差异。
{"title":"Hospitalizaciones por el síndrome de Takotsubo en España. Datos del CMBD por comunidades autónomas (años 2008-2021)","authors":"N. Rosillo ,&nbsp;N. del Prado ,&nbsp;P. Pérez ,&nbsp;J.L. Bernal ,&nbsp;I. Núñez-Gil ,&nbsp;Á. Gamarra ,&nbsp;L. Vilches ,&nbsp;J. Salamanca ,&nbsp;J. Elola ,&nbsp;F. Alfonso","doi":"10.1016/j.rce.2024.10.009","DOIUrl":"10.1016/j.rce.2024.10.009","url":null,"abstract":"<div><h3>Background and objectives</h3><div>Takotsubo syndrome (TTS) is an infrequent cause of acute coronary syndrome much better diagnosed in recent years. This study sought to assess the clinical profile of patients admitted with TTS in Spain and to elucidate potential regional differences in admissions and in-hospital mortality between the years 2008 and 2021.</div></div><div><h3>Methods</h3><div>Retrospective observational study of patients admitted to acute general hospitals of the Spanish National Health System with a main or secondary diagnosis of STT, using the minimum basic data set.</div></div><div><h3>Results</h3><div>A total of 12.952 hospitalization for TTS were identified. The number of hospital admissions increased exponentially from 210 in the year 2008 to 1,918 in 2021. Most patients (79.1%) were women and mean age was 72.0<!--> <!-->±<!--> <!-->12,5 years (72.5<!--> <!-->±<!--> <!-->12,2 in female; 69.9<!--> <!-->±<!--> <!-->13,4 in men; <em>P</em>&lt;.001). Associated comorbidities were frequent (44.9% arterial hypertension, 31.2% heart failure) and differed in men and women. Overall, crude in-hospital mortality was 7%. Notably, admission and in-hospital mortality rates, adjusted by age and gender, were different among the different autonomous communities.</div></div><div><h3>Conclusions</h3><div>TTS usually presents in elderly women with associated comorbidities and has a significant in-hospital mortality. Age and comorbidities differ between men and women. Relevant regional differences exist regarding admission and in-hospital mortality rates.</div></div>","PeriodicalId":21223,"journal":{"name":"Revista clinica espanola","volume":"225 3","pages":"Pages 140-147"},"PeriodicalIF":2.3,"publicationDate":"2025-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143479090","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnóstico y tratamiento de la embolia pulmonar. Recomendaciones del Grupo de Enfermedad Tromboembólica de la Sociedad Española de Medicina Interna 2024 肺栓塞的诊断和治疗。西班牙内科医学会血栓栓塞性疾病小组的建议 2024
IF 2.3 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-02-06 DOI: 10.1016/j.rce.2024.08.007
M.A. Fidalgo Fernández , O. Madridano Cobo , C. Sánchez del Hoyo , A. Rodríguez Iglesias , A.N. Muñoz-Rivas , M. Martín Asenjo
Pulmonary embolism (PE) is a disease with a rising incidence rate. This article presents the recommendations for the diagnosis and treatment of PE of the Thromboembolic Disease Group of the Spanish Society of Internal Medicine (SEMI). The main objective is to facilitate decision making to improve the diagnostic and therapeutic approach based on published evidence. The final justification of the document is to improve the comprehensive care of the patient with PE.
肺栓塞(PE)是一种发病率不断上升的疾病。本文介绍了西班牙内科医学会(SEMI)血栓栓塞性疾病小组对肺栓塞诊断和治疗的建议。其主要目的是促进决策制定,以便根据已发表的证据改进诊断和治疗方法。该文件的最终目的是改善对 PE 患者的综合治疗。
{"title":"Diagnóstico y tratamiento de la embolia pulmonar. Recomendaciones del Grupo de Enfermedad Tromboembólica de la Sociedad Española de Medicina Interna 2024","authors":"M.A. Fidalgo Fernández ,&nbsp;O. Madridano Cobo ,&nbsp;C. Sánchez del Hoyo ,&nbsp;A. Rodríguez Iglesias ,&nbsp;A.N. Muñoz-Rivas ,&nbsp;M. Martín Asenjo","doi":"10.1016/j.rce.2024.08.007","DOIUrl":"10.1016/j.rce.2024.08.007","url":null,"abstract":"<div><div>Pulmonary embolism (PE) is a disease with a rising incidence rate. This article presents the recommendations for the diagnosis and treatment of PE of the Thromboembolic Disease Group of the Spanish Society of Internal Medicine (SEMI). The main objective is to facilitate decision making to improve the diagnostic and therapeutic approach based on published evidence. The final justification of the document is to improve the comprehensive care of the patient with PE.</div></div>","PeriodicalId":21223,"journal":{"name":"Revista clinica espanola","volume":"225 3","pages":"Pages 168-175"},"PeriodicalIF":2.3,"publicationDate":"2025-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143479092","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fracaso en la consecución de los objetivos de c-LDL e infrautilización de tratamientos hipolipemiantes en pacientes con riesgo cardiovascular alto y muy alto: subpoblación española del estudio europeo SANTORINI 未能实现c-低密度脂蛋白的目标以及在高心血管风险和非常高心血管风险患者中低血脂治疗的利用率不足:欧洲桑托里尼研究的西班牙亚人群
IF 2.3 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-02-01 DOI: 10.1016/j.rce.2024.09.004
J.M. Mostaza , L. García-Ortiz , M.A. Suárez Tembra , P. Talavera Calle , J. Chimeno García , V. Escolar Pérez , J.L. Díaz-Díaz , L. Manzano-Espinosa , A.L. Catapano , K.K. Ray , G. Díaz Moya , J. Pedro-Botet Montoya , en representación del grupo de investigadores de SANTORINI España

Introduction

There are very few studies evaluating lipid-lowering treatments (LLTs) and low-density lipoprotein-cholesterol (LDL-C) goal attainment after the release of the 2019 guidelines of the European Societies of Cardiology (ESC) and Atherosclerosis (EAS). This manuscript shows baseline data of the Spanish subset from SANTORINI study (namely SANTORINI Spain) on LDL-C goal attainment and use of LLTs in patients at high and very high cardiovascular risk.

Methods

SANTORINI was a multinational, prospective, observational study involving patients at high and very high cardiovascular risk from 14 European countries in primary care and specialized healthcare settings. Sociodemographic data, blood lipid levels, and lipid treatments from the 1018 Spanish participants, were separately analyzed and were put into perspective with the European cohort without Spanish participants.

Results

According to physicians, 295 (29.0%) subjects were classified as high, and 723 (71.0%) as very high cardiovascular risk. Overall, 26.5% attained risk-based LDL-C targets recommended by 2019 European guidelines, with 23.1% of patients at high cardiovascular risk and 27.9% at very high cardiovascular risk. High-intensity statin therapy in monotherapy was used in 21.8%, LLT combination therapy in 41.2%, and 10.7% were not receiving any LLT.

Conclusions

Baseline data from SANTORINI Spain population show that only about one-fourth of patients attain LDL-C targets recommended by the 2019 ESC/EAS guidelines in patients at high and very high risk. Despite their cardiovascular risk, patients appear to be not adequately treated, and high-intensity and combination LLT seem to be underused for cardiovascular disease prevention in the real-world setting. ClinicalTrials.gov Identifier: NCT04271280.
在欧洲心脏病学会(ESC)和动脉粥样硬化学会(EAS) 2019年指南发布后,很少有研究评估降脂治疗(llt)和低密度脂蛋白-胆固醇(LDL-C)目标的实现。本文显示了来自SANTORINI研究(即SANTORINI西班牙)的西班牙亚群的基线数据,该数据涉及心血管风险高和极高的患者LDL-C目标的实现和llt的使用。ssantorini是一项跨国、前瞻性、观察性研究,涉及来自14个欧洲国家初级保健和专业医疗机构的高和极高心血管风险患者。对1018名西班牙参与者的社会人口统计数据、血脂水平和血脂治疗进行单独分析,并与没有西班牙参与者的欧洲队列进行比较。结果295人(29.0%)心血管风险高,723人(71.0%)心血管风险极高。总体而言,26.5%的患者达到了2019年欧洲指南推荐的基于风险的LDL-C目标,其中23.1%的患者心血管风险高,27.9%的患者心血管风险极高。21.8%的患者在单药治疗中使用高强度他汀类药物治疗,41.2%的患者使用LLT联合治疗,10.7%的患者未接受任何LLT治疗。来自圣托里尼西班牙人群的基线数据显示,在高风险和极高风险患者中,只有约四分之一的患者达到了2019年ESC/EAS指南推荐的LDL-C目标。尽管存在心血管风险,但患者似乎没有得到充分治疗,高强度和联合LLT似乎没有充分用于现实环境中的心血管疾病预防。ClinicalTrials.gov标识符:NCT04271280。
{"title":"Fracaso en la consecución de los objetivos de c-LDL e infrautilización de tratamientos hipolipemiantes en pacientes con riesgo cardiovascular alto y muy alto: subpoblación española del estudio europeo SANTORINI","authors":"J.M. Mostaza ,&nbsp;L. García-Ortiz ,&nbsp;M.A. Suárez Tembra ,&nbsp;P. Talavera Calle ,&nbsp;J. Chimeno García ,&nbsp;V. Escolar Pérez ,&nbsp;J.L. Díaz-Díaz ,&nbsp;L. Manzano-Espinosa ,&nbsp;A.L. Catapano ,&nbsp;K.K. Ray ,&nbsp;G. Díaz Moya ,&nbsp;J. Pedro-Botet Montoya ,&nbsp;en representación del grupo de investigadores de SANTORINI España","doi":"10.1016/j.rce.2024.09.004","DOIUrl":"10.1016/j.rce.2024.09.004","url":null,"abstract":"<div><h3>Introduction</h3><div>There are very few studies evaluating lipid-lowering treatments (LLTs) and low-density lipoprotein-cholesterol (LDL-C) goal attainment after the release of the 2019 guidelines of the European Societies of Cardiology (ESC) and Atherosclerosis (EAS). This manuscript shows baseline data of the Spanish subset from SANTORINI study (namely SANTORINI Spain) on LDL-C goal attainment and use of LLTs in patients at high and very high cardiovascular risk.</div></div><div><h3>Methods</h3><div>SANTORINI was a multinational, prospective, observational study involving patients at high and very high cardiovascular risk from 14 European countries in primary care and specialized healthcare settings. Sociodemographic data, blood lipid levels, and lipid treatments from the 1018 Spanish participants, were separately analyzed and were put into perspective with the European cohort without Spanish participants.</div></div><div><h3>Results</h3><div>According to physicians, 295 (29.0%) subjects were classified as high, and 723 (71.0%) as very high cardiovascular risk. Overall, 26.5% attained risk-based LDL-C targets recommended by 2019 European guidelines, with 23.1% of patients at high cardiovascular risk and 27.9% at very high cardiovascular risk. High-intensity statin therapy in monotherapy was used in 21.8%, LLT combination therapy in 41.2%, and 10.7% were not receiving any LLT.</div></div><div><h3>Conclusions</h3><div>Baseline data from SANTORINI Spain population show that only about one-fourth of patients attain LDL-C targets recommended by the 2019 ESC/EAS guidelines in patients at high and very high risk. Despite their cardiovascular risk, patients appear to be not adequately treated, and high-intensity and combination LLT seem to be underused for cardiovascular disease prevention in the real-world setting. ClinicalTrials.gov Identifier: <span><span>NCT04271280</span><svg><path></path></svg></span>.</div></div>","PeriodicalId":21223,"journal":{"name":"Revista clinica espanola","volume":"225 2","pages":"Pages 78-84"},"PeriodicalIF":2.3,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143137448","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
La desnutrición en la insuficiencia cardíaca. La importancia de evaluar la congestión y la sarcopenia 心力衰竭中的营养不良。评估充血和骨骼肌减少症的重要性
IF 2.3 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-02-01 DOI: 10.1016/j.rce.2024.09.005
J. Carretero Gómez , T.F. Galeano Fernández , A.S. Vidal Ríos , S. Tolosa Álvarez , M. Sánchez Herrera , C. García Carrasco , F.J. Monreal Periañez , P. González González , J.C. Arévalo Lorido

Objective

This work aims to describe nutrition and sarcopenia in inpatients with heart failure (HF). It also aims to assess factors associated with in-hospital and short-term prognosis related to nutrition and sarcopenia.

Methods

We collected data on consecutive HF patients admitted to a single center's internal medicine ward. Patients were recruited in May and October 2021. Malnutrition was determined by the Mini Nutritional Assessment-Short Form (MNA-SF) and sarcopenia by the screening test, SARC-F scale, and handgrip strength test.

Results

190 patients were analyzed, mean age 82.1 (± 8.2), 54.2% women, median follow up 106 days. Patients were classified into three groups based on MNA-SF score: group 1 (12-14 points, no risk) included 50 patients, group 2 (8-12 points, high risk of malnutrition) included 81 patients, group 3 (0-7 points, malnourished) included 59 patients. Group 3 had significantly more inflammation (lower albumin and higher C-reactive Protein (CRP)) and congestion (mea-sured by NT-ProBNP levels). In-hospital mortality was related to poor muscle function, CRP, andNT-ProBNP, but not to malnutrition. The poorest short-term outcomes were related to malnutrition and comorbidity. However, when the variable of muscle function was introduced, it could act as a poor prognostic factor related to CRP and NT-ProBNP, which were the main determinantsof survival.

Conclusion

In malnourished patients with HF, inflammation and congestion were related to in-hospital mortality. Malnutrition along with comorbidity may play a role in decreasing short-term survival. Early identification through proactive nutritional and functional screenings should be a key element of assessing HF patients.
目的探讨心力衰竭(HF)住院患者营养与肌肉减少症的关系。它还旨在评估与营养和肌肉减少症相关的住院和短期预后相关的因素。方法收集同一中心内科病房连续收治的心衰患者的资料。患者于2021年5月和10月招募。营养不良通过迷你营养评估简表(MNA-SF)确定,肌肉减少症通过筛选试验、SARC-F量表和握力测试确定。结果分析190例患者,平均年龄82.1(±8.2)岁,女性54.2%,中位随访106天。根据MNA-SF评分将患者分为3组:1组(12-14分,无风险)50例,2组(8-12分,营养不良高风险)81例,3组(0-7分,营养不良)59例。第3组有明显更多的炎症(较低的白蛋白和较高的c反应蛋白(CRP))和充血(通过NT-ProBNP水平测量)。住院死亡率与肌肉功能差、CRP和nt - probnp有关,但与营养不良无关。最糟糕的短期结果与营养不良和合并症有关。然而,当引入肌肉功能变量时,它可能作为与CRP和NT-ProBNP相关的不良预后因素,而CRP和NT-ProBNP是生存的主要决定因素。结论在营养不良的心衰患者中,炎症和充血与住院死亡率有关。营养不良与合并症可能在降低短期生存率中起作用。通过积极的营养和功能筛查进行早期识别应该是评估心衰患者的关键因素。
{"title":"La desnutrición en la insuficiencia cardíaca. La importancia de evaluar la congestión y la sarcopenia","authors":"J. Carretero Gómez ,&nbsp;T.F. Galeano Fernández ,&nbsp;A.S. Vidal Ríos ,&nbsp;S. Tolosa Álvarez ,&nbsp;M. Sánchez Herrera ,&nbsp;C. García Carrasco ,&nbsp;F.J. Monreal Periañez ,&nbsp;P. González González ,&nbsp;J.C. Arévalo Lorido","doi":"10.1016/j.rce.2024.09.005","DOIUrl":"10.1016/j.rce.2024.09.005","url":null,"abstract":"<div><h3>Objective</h3><div>This work aims to describe nutrition and sarcopenia in inpatients with heart failure (HF). It also aims to assess factors associated with in-hospital and short-term prognosis related to nutrition and sarcopenia.</div></div><div><h3>Methods</h3><div>We collected data on consecutive HF patients admitted to a single center's internal medicine ward. Patients were recruited in May and October 2021. Malnutrition was determined by the Mini Nutritional Assessment-Short Form (MNA-SF) and sarcopenia by the screening test, SARC-F scale, and handgrip strength test.</div></div><div><h3>Results</h3><div>190 patients were analyzed, mean age 82.1 (±<!--> <!-->8.2), 54.2% women, median follow up 106 days. Patients were classified into three groups based on MNA-SF score: group 1 (12-14 points, no risk) included 50 patients, group 2 (8-12 points, high risk of malnutrition) included 81 patients, group 3 (0-7 points, malnourished) included 59 patients. Group 3 had significantly more inflammation (lower albumin and higher C-reactive Protein (CRP)) and congestion (mea-sured by NT-ProBNP levels). In-hospital mortality was related to poor muscle function, CRP, andNT-ProBNP, but not to malnutrition. The poorest short-term outcomes were related to malnutrition and comorbidity. However, when the variable of muscle function was introduced, it could act as a poor prognostic factor related to CRP and NT-ProBNP, which were the main determinantsof survival.</div></div><div><h3>Conclusion</h3><div>In malnourished patients with HF, inflammation and congestion were related to in-hospital mortality. Malnutrition along with comorbidity may play a role in decreasing short-term survival. Early identification through proactive nutritional and functional screenings should be a key element of assessing HF patients.</div></div>","PeriodicalId":21223,"journal":{"name":"Revista clinica espanola","volume":"225 2","pages":"Pages 92-100"},"PeriodicalIF":2.3,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143137918","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Revista clinica espanola
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1